BioSpace News Archive

The new Kerecis telemedicine service, TeleKer™, enables healthcare providers to get timely, personalized advice on how to treat wounds with Kerecis products.

EnvisionTEC, a leading global manufacturer of desktop and full-production 3D printers and materials, is proud to announce they have successfully completed a clinical trial to use the EnvisionTEC 3D printed Nasopharyngeal (NP) Swabs for COVID-19 testing.

Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced that first quarter of fiscal year 2020 financial results will be released after the market closes on Thursday, May 14, 2020.

Conference Call and Webcast Scheduled for Wednesday, May 6

Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna Zentaris” or the “Company”), a specialty biopharmaceutical company commercializing and developing therapeutics and diagnostic tests, today announced that on April 8, 2020, the Company received notice from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company is not in compliance with the minimum $1.00 per share b

As the COVID-19 pandemic continues to strain not just the physical and emotional well-being of front-line healthcare workers, many are also facing a financial burden and strain on their personal lives.

Fund will help team members with rent, groceries, dependent care and other needs

UroGen Pharma Ltd. (Nasdaq: URGN) today announced the U.S. Food and Drug Administration (FDA) granted expedited approval for Jelmyto™ (mitomycin) for pyelocalyceal solution, a first-in-class treatment indicated for adults with low-grade upper tract urothelial cancer (LG UTUC).

Medicure Inc. (“Medicure” or the “Company”) (TSXV:MPH, OTC:MCUJF), a pharmaceutical company, today reported its results from operations for the quarter and year ended December 31, 2019.

The U.S. Food and Drug Administration announced the following actions taken in its ongoing response effort to the COVID-19 pandemic